Huilai Miao
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 3
-
- RNA modifications and cancer 3
-
- Liver Disease and Transplantation 3
- Liver physiology and pathology 2
-
- Pancreatic and Hepatic Oncology Research 3
- Cancer-related Molecular Pathways 3
-
- Liver Disease Diagnosis and Treatment 6
-
- Pediatric Hepatobiliary Diseases and Treatments 2
- Journals
- PLoS ONE (1 paper)Journal of Lipid Research (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Huilai Miao
34 papers receiving 763 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 180
- Molecular Biology 428
- Hepatology 45
- Oncology 139
- Complementary and alternative medicine 41
Countries citing papers authored by Huilai Miao
This map shows the geographic impact of Huilai Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huilai Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huilai Miao more than expected).
Fields of papers citing papers by Huilai Miao
This network shows the impact of papers produced by Huilai Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huilai Miao. The network helps show where Huilai Miao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huilai Miao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 8 | |
| 8 | 2020 | 63 | |
| 9 | 2020 | 8 | |
| 10 | 2020 | 12 | |
| 11 | 2019 | 4 | |
| 12 | 2019 | 21 | |
| 13 | 2017 | 29 | |
| 14 | 2016 | 11 | |
| 15 | 2016 | 46 | |
| 16 | 2015 | 67 | |
| 17 | 2015 | 35 | |
| 18 | 2014 | 40 | |
| 19 | 2013 | 42 | |
| 20 | 2012 | 40 |
About Huilai Miao
Huilai Miao is a scholar working on Hepatology, Cancer Research and Geriatrics and Gerontology, having authored 36 papers that have together received 771 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (3 papers), Liver Disease and Transplantation (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (3 papers), Liver physiology and pathology (2 papers) and Pediatric Hepatobiliary Diseases and Treatments (2 papers). The work is most often cited by research in Cancer Research (180 citations), Molecular Biology (428 citations) and Hepatology (45 citations). Huilai Miao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mingyi Li, Bin Liang, Linqiang Zhang, Tingting Zhu, Nianping Chen, Wenxue Ma, Xiaotang Ma, Runzhi Zhu, Jie Liu and Yanfang Chen. Their work appears in journals such as PLoS ONE, Journal of Lipid Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.